Transmission of metallo-β-lactamase-producing Pseudomonas aeruginosa in a nephrology-transplant intensive care unit with potential link to the environment

Journal of Hospital Infection

Volumn 92, Issue 1, 2016, Pages 27-29

  Ambrogi, V ^a   Cavalie L ^a,b   Mantion, B ^a   Ghiglia, M J ^a   Cointault, O ^a   Dubois, D ^a,b   Prere M F ^a,c   Levitzki, N ^a   Kamar, N ^a,c   Malavaud, S ^a  

^a TOULOUSE UNIVERSITY HOSPITAL   (France)

^b University of Toulouse III   (France)

^c UNIVERSITÉ PAUL SABATIER   (France)

Author keywords

Environmental source; Intensive care unit; Pseudomonas aeruginosa; VIM carbapenemase

Indexed keywords

AMIKACIN; AZTREONAM; BETA LACTAM ANTIBIOTIC; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; TAZOBACTAM; TICARCILLIN; TOBRAMYCIN; BACTERIAL PROTEIN; BETA LACTAMASE; CARBAPENEMASE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL TRANSMISSION; BACTERIUM CONTAMINATION; BLOODSTREAM INFECTION; CLINICAL ARTICLE; HUMAN; INTENSIVE CARE; KIDNEY TRANSPLANTATION; METALLO BETA LACTAMASE PRODUCING PSEUDOMONAS AERUGINOSA; NONHUMAN; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION; WATER SUPPLY; CASE REPORT; CLASSIFICATION; DISEASE TRANSMISSION; ENZYMOLOGY; GRAFT RECIPIENT; INTENSIVE CARE UNIT; ISOLATION AND PURIFICATION; MICROBIOLOGY; SECRETION (PROCESS); TRANSMISSION;

BACTERIAL PROTEINS; BETA-LACTAMASES; DISEASE TRANSMISSION, INFECTIOUS; ENVIRONMENTAL MICROBIOLOGY; HUMANS; INTENSIVE CARE UNITS; KIDNEY TRANSPLANTATION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; TRANSPLANT RECIPIENTS;

EID: 84952976579     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2015.09.007     Document Type: Article

References (9)

1. Aspelund AS, Liljequist BO, Melander E. Nosocomial spread of metallo-beta-lactamase producing Pseudomonas aeruginosa in a University Hospital with possible link to sink drains: The 9th Healthcare Infection Society International Conference 2014, November 16th-18th, 2014, Lyon, France.
2. Breathnach A.S., Cubbon M.D., Karunaharan R.N., Pope C.F., Planche T.D. Multidrug-resistant Pseudomonas aeruginosa outbreaks in two hospitals: association with contaminated hospital waste-water systems. J Hosp Infect 2012, 82:19-24.
3. Viedma E., Juan C., Villa J., et al. VIM-2-producing multidrug-resistant Pseudomonas aeruginosa ST175 Clone, Spain. Emerg Infect Dis 2012, 18:1235-1241.
4. Pitout J.D., Chow B.L., Gregson D.B., et al. Molecular epidemiology of metallo-beta-lactamase-producing Pseudomonas aeruginosa in the Calgary Health Region: emergence of VIM-2-producing isolate. J Clin Microbiol 2007, 45:294-298.
5. Tenover F.C., Arbeit R.D., Goering R.V., et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995, 33:2233-2239.
6. Nseir S., Blazejewski C., Lubret R., Wallet F., Courcol R., Durocher A. Risk of acquiring multidrug-resistant Gram-negative bacilli from prior room occupants in the intensive care unit. Clin Microbiol Infect 2011, 17:1201-1208.
7. Hirakata Y., Yamaguchi T., Nakano M., et al. Clinical and bacteriological characteristics of IMP-type metallo-beta-lactamase-producing Pseudomonas aeruginosa. Clin Infect Dis 2003, 37:26-32.
8. Hota S., Hirji Z., Stockton K., et al. Outbreak of multidrug-resistant Pseudomonas aeruginosa colonization and infection secondary to imperfect intensive care unit room design. Infect Control Hosp Epidemiol 2009, 30:25-33.
9. Venier A.G., Leroyer C., Slekovec C., et al. Risk factors for Pseudomonas aeruginosa acquisition in intensive care units: a prospective multicentre study. J Hosp Infect 2014, 88:103-108.